MARKER THERAPEUTICS, INC. Increase (Decrease) in Contract Receivables, Net
MARKER THERAPEUTICS, INC. (MRKR) reported Increase (Decrease) in Contract Receivables, Net of -$1.05 thousand for the 179-month period ending 2014-06-30, per its 10-Q filed 2014-08-18.
Discontinued › Notes
us-gaap:IncreaseDecreaseInContractReceivablesNet · last filed 2014-08-18
- MARKER THERAPEUTICS, INC. increase (decrease) in contract receivables, net for the quarter ending 2012-06-30 was -$24.00.
- MARKER THERAPEUTICS, INC. increase (decrease) in contract receivables, net for the quarter ending 2012-03-31 was $24.00, a 63.08% decline year-over-year.
- MARKER THERAPEUTICS, INC. increase (decrease) in contract receivables, net for the quarter ending 2011-06-30 was -$65.00.
- MARKER THERAPEUTICS, INC. increase (decrease) in contract receivables, net for the quarter ending 2011-03-31 was $65.00.
- MARKER THERAPEUTICS, INC. increase (decrease) in contract receivables, net for fiscal 2012 was -$22.00, a 269.23% decline from fiscal 2011.
- MARKER THERAPEUTICS, INC. increase (decrease) in contract receivables, net for fiscal 2011 was $13.00, a 58.06% decline from fiscal 2010.
- MARKER THERAPEUTICS, INC. increase (decrease) in contract receivables, net for fiscal 2010 was $31.00.
| Period end | Increase (Decrease) in Contract Receivables, Net 3 month | Increase (Decrease) in Contract Receivables, Net 6 month | Increase (Decrease) in Contract Receivables, Net 9 month | Increase (Decrease) in Contract Receivables, Net 12 month | Increase (Decrease) in Contract Receivables, Net 143 month | Increase (Decrease) in Contract Receivables, Net 146 month | Increase (Decrease) in Contract Receivables, Net 149 month | Increase (Decrease) in Contract Receivables, Net 152 month | Increase (Decrease) in Contract Receivables, Net 155 month | Increase (Decrease) in Contract Receivables, Net 158 month | Increase (Decrease) in Contract Receivables, Net 161 month | Increase (Decrease) in Contract Receivables, Net 164 month | Increase (Decrease) in Contract Receivables, Net 167 month | Increase (Decrease) in Contract Receivables, Net 170 month | Increase (Decrease) in Contract Receivables, Net 173 month | Increase (Decrease) in Contract Receivables, Net 179 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2014-06-30 | -$1.05K 10-Q · filed 2014-08-18 | |||||||||||||||
| 2013-12-31 | $1.05K 10-Q/A · filed 2014-05-21 | |||||||||||||||
| 2013-09-30 | $1.05K 10-Q · filed 2013-11-19 | |||||||||||||||
| 2013-06-30 | $1.05K 10-Q · filed 2013-08-19 | |||||||||||||||
| 2013-03-31 | $1.05K 10-Q/A · filed 2013-08-19 | |||||||||||||||
| 2012-12-31 | -$22.00 10-K/A · filed 2014-04-17 | $1.05K 10-K · filed 2013-05-15 | ||||||||||||||
| 2012-09-30 | $1.08K 10-Q · filed 2012-11-19 | |||||||||||||||
| 2012-06-30 | -$24.00 derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2012-09-12 | $0.00 10-Q/A · filed 2012-09-12 | $1.08K 10-Q/A · filed 2012-09-12 | |||||||||||||
| 2012-03-31 | $24.00 10-Q/A · filed 2013-08-19 | $1.10K 10-Q · filed 2012-05-21 | ||||||||||||||
| 2011-12-31 | $13.00 10-K · filed 2013-05-15 | $1.08K 10-K · filed 2012-04-16 | ||||||||||||||
| 2011-09-30 | $1.06K 10-Q · filed 2011-11-21 | |||||||||||||||
| 2011-06-30 | -$65.00 derived: 10-Q/A 6 month − 10-Q 3 month · filed 2012-09-12 | $0.00 10-Q/A · filed 2012-09-12 | $0.00 derived: sum of 3 quarters · filed 2012-09-12 | $0.00 derived: sum of 4 quarters · filed 2012-09-12 | $1.06K 10-Q · filed 2011-08-22 | |||||||||||
| 2011-03-31 | $65.00 10-Q · filed 2012-05-21 | $65.00 derived: sum of 2 quarters · filed 2012-05-21 | $65.00 derived: sum of 3 quarters · filed 2012-05-21 | |||||||||||||
| 2010-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-04-16 | $0.00 derived: sum of 2 quarters · filed 2012-04-16 | $31.00 10-K · filed 2012-04-16 | |||||||||||||
| 2010-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-21 | $31.00 10-Q · filed 2011-11-21 | ||||||||||||||
| 2010-06-30 | $31.00 10-Q · filed 2011-08-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |